Diagnostic criteria of cachexia and their assessment: decreased muscle strength and fatigue
暂无分享,去创建一个
[1] G. Yue,et al. Cancer-related fatigue: central or peripheral? , 2009, Journal of pain and symptom management.
[2] T. Furukawa,et al. Factors correlated with fatigue in terminally ill cancer patients: a longitudinal study. , 2008, Journal of pain and symptom management.
[3] P. Stone,et al. Fatigue in palliative care patients — an EAPC approach , 2008, Palliative medicine.
[4] M. C. Boruban,et al. The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma. , 2007, European journal of cancer care.
[5] K. Courneya,et al. Possible links between behavioral and physiological indices of tiredness, fatigue, and exhaustion in advanced cancer , 2008, Supportive Care in Cancer.
[6] L. Oldervoll,et al. Assessing physical functioning: a systematic review of quality of life measures developed for use in palliative care , 2007, Palliative medicine.
[7] D. Osoba,et al. Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] E. Shaw,et al. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] I. Bosaeus,et al. Daily Physical-Rest Activities in Relation to Nutritional State, Metabolism, and Quality of Life in Cancer Patients with Progressive Cachexia , 2007, Clinical Cancer Research.
[10] I. Hickie,et al. Postinfective fatigue syndrome is not associated with altered cytokine production. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] R. Skipworth,et al. Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. , 2007, Journal of pain and symptom management.
[12] P. Jean-Pierre,et al. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. , 2007, The oncologist.
[13] M. Perlis,et al. Cancer-related fatigue and sleep disorders. , 2007, The oncologist.
[14] P. Jean-Pierre,et al. Cancer-related fatigue: the scale of the problem. , 2007, The oncologist.
[15] Kevin Fiscella,et al. Mechanisms of cancer-related fatigue. , 2007, The oncologist.
[16] H. Friess,et al. Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia , 2007, Journal of Molecular Medicine.
[17] E. Bruera,et al. Palliative management of fatigue at the close of life: "it feels like my body is just worn out". , 2007, JAMA.
[18] Nicholas F Taylor,et al. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry. , 2007, Archives of physical medicine and rehabilitation.
[19] E. Bruera,et al. The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer , 2006, Cancer.
[20] S. Kritchevsky,et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[21] K. Chamari,et al. Comparison of muscle mechanical and histochemical properties between young and elderly subjects. , 2006, International journal of sports medicine.
[22] E. Bruera,et al. Symptom control in palliative care--Part II: cachexia/anorexia and fatigue. , 2006, Journal of palliative medicine.
[23] F. López‐Soriano,et al. Muscle wasting in cancer and ageing: cachexia versus sarcopenia. , 2006, Advances in gerontology = Uspekhi gerontologii.
[24] Romain Meeusen,et al. Central Fatigue , 2006, Sports medicine.
[25] Declan Walsh,et al. Symptom clustering in advanced cancer , 2006, Supportive Care in Cancer.
[26] S. Nadeau,et al. Reliability and validity of static knee strength measurements obtained with a chair-fixed dynamometer in subjects with hip or knee arthroplasty. , 2005, Archives of physical medicine and rehabilitation.
[27] D. Taillandier,et al. The ubiquitin-proteasome system and skeletal muscle wasting. , 2005, Essays in biochemistry.
[28] D. V. Von Hoff,et al. A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] L. Saltz,et al. Cetuximab therapy and symptomatic hypomagnesemia. , 2005, Journal of the National Cancer Institute.
[30] M. Albitar,et al. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome , 2005, Cancer.
[31] M. Tisdale. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. , 2005, The journal of supportive oncology.
[32] E. Bruera,et al. Effects of parenteral hydration in terminally ill cancer patients: a preliminary study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] D. McMillan,et al. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer , 2005, Cancer.
[34] Dieter Felsenberg,et al. Is muscle power output a key factor in the age‐related decline in physical performance? A comparison of muscle cross section, chair‐rising test and jumping power , 2004, Clinical physiology and functional imaging.
[35] J. Tariman,et al. Bortezomib, a newly approved proteasome inhibitor for the treatment of multiple myeloma: nursing implications. , 2004, Clinical journal of oncology nursing.
[36] P. Fayers,et al. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors , 2003, Palliative medicine.
[37] Eduardo Bruera,et al. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea , 2003, Palliative medicine.
[38] Sharon L Olson,et al. Test-retest strength reliability: hand-held dynamometry in community-dwelling elderly fallers. , 2002, Archives of physical medicine and rehabilitation.
[39] C. Bing,et al. Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans , 2002, British Journal of Cancer.
[40] P. Stone,et al. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. , 2001, Journal of pain and symptom management.
[41] Y. Nishiwaki,et al. Fatigue in ambulatory patients with advanced lung cancer: prevalence, correlated factors, and screening. , 2001, Journal of pain and symptom management.
[42] J. Davis,et al. Serotonin and central nervous system fatigue: nutritional considerations. , 2000, The American journal of clinical nutrition.
[43] C. Baird,et al. The pilot study. , 2000, Orthopedic nursing.
[44] F. Bozzetti,et al. Effects of cachexia due to cancer on whole body and skeletal muscle protein turnover , 1998, Cancer.
[45] D. Cella,et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. , 1997, Journal of pain and symptom management.